iBET’s work on cardiac fibrosis presented at Antibody Engineering & Therapeutics Europe

Daniel Simão, Head of Bayer Pharma Satellite Lab at iBET, was invited to present a talk entitled “In Vitro Tools to explore Cardiac Fibrosis Target Space” at the Antibody Engineering & Therapeutics Europe meeting on June 6th, in Amsterdam, the Netherlands.

Cardiac fibrosis is a pathology typically associated with limited cardiac function, with no effective therapies currently available.

In this presentation, Daniel shared their research on profiling cardiac fibroblasts using omic technologies for target prioritization. In addition, whole cell planning strategies using phage display technology was also discussed; aiming to isolate antibodies with therapeutic potential.

Learn more about this conference here